TrialPath
Recruiting

Reliability and Validity of the Turkish Version of General Sleep Disturbance Scale (GSDS-T) in Multiple Sclerosis

NCT06875908 · Istanbul Medeniyet University
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

About this study
The GSDS-T was developed by Lee KA to assess difficulty falling asleep, waking up during sleep, sleep quality, and daytime alertnes. The Turkish validity and reliability of the scale has been conducted on stroke patients but not on multiple sclerosis patients. The aim of this study is to investigate the validity and reliability of the Turkish version of general sleep disturbance scale (GSDS-T) in patients with multiple sclerosis. GSD has 21 questions. This study will be conducted on patients with multiple sclerosis (MS). 126 participants will be included in the study. In order to evaluate the validity of the GSDS-T, the Pittsburgh Sleep Quality Index (PSQI) which can evaluate sleep quality and has been validated in Turkish, will be used. Scales will be repeated after 15 days to assess test-retest reliability.
Eligibility criteria
Inclusion Criteria: * Individuals over the age of 18 who have been diagnosed with Multiple Sclerosis for at least two years, * Those with an EDSS score \>2. * Those without symptoms of insomnia according to the Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) diagnostic criteria * Individuals whose native language is Turkish and who have the ability to speak and understand. Exclusion Criteria: * Those with severe spasticity, * Those with vision and hearing problems, * Those with a known mental illness (major depression, schizophrenia, psychosis, etc.), * Those in an acute relapse phase, * Those using dietary supplements, * Those using tranquilizers or immunosuppressants.
Study design
Enrollment target: 126 participants
Age groups: adult, older_adult
Timeline
Starts: 2025-04-15
Estimated completion: 2025-08-10
Last updated: 2025-06-17
Interventions
Other: Turkish Validity and Reliability of The GSDS-T in patients with multiple sclerosis
Primary outcomes
  • • Sleep disturbances (baseline)
  • • Sleep quality (baseline)
Sponsor
Istanbul Medeniyet University · other
Contacts & investigators
ContactEMEL METE · contact · meteemel53@gmail.com · +905376096265
All locations (1)
Bağcılar Training and Research HospitalRecruiting
Bağcılar, Istanbul, Turkey (Türkiye)